Ecolab Life Sciences Introduces Klercide™ Rapid Sporicide for Cleanroom Applications

New solution reduces time and costs to meet the modern demands of pharmaceutical production.

October 29, 2025

St. Paul, Minn. - October 29, 2025 - Ecolab Life Sciences today announced the launch of its Klercide™ Rapid Sporicide, a new sporicidal disinfectant designed to elevate pharmaceutical cleanroom safety and performance, while reducing overall production turnover time. This new pharma cleanroom product is milder on equipment and surfaces and helps improve user experience along with work conditions.

Ecolab's latest pharma cleanroom sporicide addresses long-standing challenges in pharma microbial control, like strong odors, corrosiveness, and full surface coverage, all of which contribute to a reduced lifetime of equipment and a less desirable work environment for operators. This new formula is a market-changing innovation, delivering efficacy while minimizing residue, reducing re-application time and enhancing the overall user experience. This leads to shorter changeover times and overall savings for pharmaceutical manufacturers, helping deliver safely made medicines to patients faster. The new sporicide will be available in a variety of formats to meet the entire lifecycle of pharma production.

"Cleanroom operators and pharmaceutical manufacturers have long sought a sporicide solution that balances efficacy and usability, without the strong odor or corrosiveness associated with existing solutions," said Meg Carr, vice president & general manager, Ecolab Life Sciences. "Klercide Rapid Sporicide represents a significant advancement in cleanroom contamination control and underpins Ecolab's commitment to creating a measurable impact in safe manufacturing."

Klercide Rapid Sporicide is registered with the Environmental Protection Agency (EPA Reg. No. 1677-288) for use against bacterial spores, fungi, and other hard-to-kill microorganisms. State registrations are in process.

Further information regarding the new solution can also be viewed at the Ecolab Life Sciences website here.

About Ecolab

A trusted partner for millions of customers, Ecolab (NYSE:ECL) is a global sustainability leader offering water, hygiene and infection prevention solutions and services that protect people and the resources vital to life. Building on more than a century of innovation, Ecolab has annual sales of $16 billion, employs approximately 48,000 associates and operates in more than 170 countries around the world. The company delivers comprehensive science-based solutions, data-driven insights and world-class service to advance food safety, maintain clean and safe environments, and optimize water and energy use. Ecolab's innovative solutions improve operational efficiencies and sustainability for customers in the food, healthcare, high tech, life sciences, hospitality and industrial markets. www.ecolab.com

Follow us on LinkedIn @Ecolab, Instagram @Ecolab_Inc and Facebook @Ecolab.

Related News

qatest011

Ecolab Announces Record Fourth Quarter and Strong 2026 Outlook; Reported Diluted EPS $1.98; Adjusted Diluted EPS $2.08, +15%; 2026 Adjusted Diluted EPS Outlook: $8.43 - $8.63, +12% - 15%

Ecolab Inc. (NYSE: ECL): FOURTH QUARTER HIGHLIGHTS Ecolab delivered another quarter of strong double-digit EPS growth, d...

Accelerating innovation and sustainability in tissue manufacturing

Accelerating innovation and sustainability in tissue manufacturing...

Ecolab Schedules Webcast and Conference Call on February 10, 2026

Ecolab will host a live webcast to discuss its 2025 fourth quarter results. A news release containing fourth quarter res...

News12

Ecolab Strengthens Integrated Cooling Program for Data Centers

Innovative 360⁰ program supports accelerated data center growth at global scale Ecolab Inc., a global sustainability lea...

Ecolab Named Top 10 Enterprise-wide Honoree at GEN IMPACT Awards

Ecolab’s Employee Resource Groups are advancing innovation, empowering teams and enhancing brand reputation through incl...

News5